Literature DB >> 1812317

[Kidney function of patients with healthy kidneys during cyclosporin treatment].

P Heering1, B Kutkuhn, G Kreuzpaintner, T Reinhard, R Sundmacher, B Grabensee.   

Abstract

Long-term administration of ciclosporin has been complicated by side-effects, the predominant being nephrotoxicity. We performed renal function studies on 20 patients treated with ciclosporin (group 1) and on 12 patients serving as controls (group 2). Only patients with serum creatinine less than 1.3 mg/dl entered the study. The renal function studies consisted of: Inulin clearance, PAH clearance, sodium sulphate loading, sodium bicarbonate loading. Plasma renin activity (PRA), inactive renin (IR) and aldosterone (ALDO) were measured basally and after stimulation with 40 mg furosemide i.v. Serum creatinine was not significantly impaired under ciclosporin with 1.1 +/- 0.1 mg/dl vs 0.9 +/- 0.1 mg/dl in the control group (ns). Glomerular filtration rates as measured by creatinine and inulin clearance were significantly impaired in group 1 as compared to group 2. Inulin clearance was impaired by ciclosporin with 93.5 +/- 4.4 ml/min/1.73 m2 as compared to 121 +/- 6.6 ml/min/1.73 m2 (p less than 0.05) in patients of group 2. The PAH clearance in ciclosporin treated patients was impaired, with 379 +/- 22.1 ml/min/1.73 m2 in group 1 as compared to 605 +/- 39 ml/min/1.73 m2 (p less than 0.001) in group 2. Mean arterial pressure and renovascular resistance were significantly increased in ciclosporin treated patients. We demonstrated, by means of sodium sulphate and bicarbonate loading, incomplete distal tubular acidosis in 3 patients from group 1 but in none of group 2. There was no difference in basal plasma renin activity (PRA), but during volume contraction induced by furosemide there was only blunted response by PRA in patients receiving ciclosporin with 2.7 +/- 0.3 ng/ml/h as compared to 7.7 +/- 0.5 ng/ml/h in controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812317     DOI: 10.1007/BF01649562

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  29 in total

1.  Acquired distal renal tubular acidosis.

Authors:  N A Kurtzman
Journal:  Kidney Int       Date:  1983-12       Impact factor: 10.612

Review 2.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

3.  Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus.

Authors:  D M Wilson; J A Luetscher
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

4.  Chronic injury of human renal microvessels with low-dose cyclosporine therapy.

Authors:  B D Myers; L Newton; C Boshkos; J A Macoviak; W H Frist; G C Derby; M G Perlroth; R K Sibley
Journal:  Transplantation       Date:  1988-11       Impact factor: 4.939

5.  Effect of short-term cyclosporine A administration on urinary acidification.

Authors:  D C Batlle; C Gutterman; J Tarka; R Prasad
Journal:  Clin Nephrol       Date:  1986       Impact factor: 0.975

6.  Suppression of plasma renin activity by cyclosporine.

Authors:  J P Bantle; R J Boudreau; T F Ferris
Journal:  Am J Med       Date:  1987-07       Impact factor: 4.965

7.  The long-term course of cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; R Sibley; L Newton; S J Tomlanovich; C Boshkos; E Stinson; J A Luetscher; D J Whitney; D Krasny; N S Coplon
Journal:  Kidney Int       Date:  1988-02       Impact factor: 10.612

8.  Hyperkalaemia in cyclosporin-treated renal allograft recipients.

Authors:  D Adu; J Turney; J Michael; P McMaster
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

9.  Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

Authors:  J J Curtis; R G Luke; E Dubovsky; A G Diethelm; J D Whelchel; P Jones
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

10.  [Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension].

Authors:  B Kutkuhn; H Chlebowski; M Hollenbeck; B Grabensee
Journal:  Z Kardiol       Date:  1989-03
View more
  3 in total

1.  Systemic ciclosporin A in high-risk keratoplasties.

Authors:  T Reinhard; R Sundmacher; P Heering
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

2.  Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorption.

Authors:  P Heering; P Schadewaldt; D Bach; B Grabensee
Journal:  Clin Investig       Date:  1993-12

3.  Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.

Authors:  I Mühlhauser; K Prange; P T Sawicki; R Bender; A Dworschak; W Schaden; M Berger
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.